Floatz logo

[18F]FluorbetaOx

Heart Failure

Washington University School of MedicineEarly Phase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

27 Active assets in the Heart Failure cohort.

Asset / SponsorPhaseRating
Empagliflozin
Jacob Moller
Phase 4BB
Finerenone
Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Phase 4BB
Semaglutide
University Medical Centre Ljubljana
Phase 2/3BB
CARVEDILOL
Abramson Cancer Center at Penn Medicine
Phase 3BB
Rivaroxaban
Janssen Research & Development, LLC
Phase 3B

View all 40 →

Same molecule, other indications

[18F]FluorbetaOx is also rated in:

type 2 diabetes mellitusDormant
CC
Indicative ·
43 / 100
View asset →
obesity disorderDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →